Brad Stanfield: The ‘Toxic’ Hormone That Just Broke Every Obesity Record

Key Takeaways

• Retatrutide, a triple hormone receptor agonist targeting GLP-1, GIP, and glucagon, produces unprecedented weight loss, averaging 24.2% of body weight at 48 weeks.
• Patients on retatrutide experienced up to 20.9% incidence of dysesthesia (abnormal skin sensations) at the highest dose, a novel side effect.
• To mitigate muscle loss, engage in resistance exercise and ensure you meet your daily protein target while on retatrutide.
• Monitor for elevated heart rates and other potential side effects, as phase 3 trials may reveal further adverse events.
• Be prepared for the high cost of retatrutide, which can exceed $1,000 per month, and understand that insurance coverage may be limited for weight loss.

Bottom Line

Consider retatrutide for significant weight loss but be aware of potential side effects like dysesthesia, prioritize protein intake and resistance training to preserve muscle, and assess affordability and insurance coverage before starting treatment.

Watch the Full Video